OskoTec Sells Drug Tech to Agios

OskoTec has made a significant deal with Agios. The company is exporting its autoimmune disease drug technology. This deal is valued at $1 billion, marking a major transaction in the pharmaceutical industry. Agios will likely utilize this technology to develop new treatments. The impact of this deal could be substantial for both companies and the industry as a whole.